Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

-

REPORT

PhRMA Special 301 Submission 2024

A detail image of the first page of PhRMA's Special 301 Submission to the Center for Medicare and Medicaid Services for 2024
PhRMA’s comments to the Office of the U.S. Trade Representative (USTR)’s 2024 Special 301 Report reinforce how the United States can defend American innovators in overseas markets and address damaging market access and intellectual property barriers abroad.

A detail image of the first page of PhRMA's Special 301 Submission to the Center for Medicare and Medicaid Services for 2024

Download FULL REPORT

-

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.